Quantbot Technologies LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Quantbot Technologies LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$100,130
+428.6%
3,331
+527.3%
0.01%
+600.0%
Q4 2022$18,941
-66.8%
531
-68.6%
0.00%
-75.0%
Q3 2022$57,000
-65.2%
1,689
-72.7%
0.00%
-66.7%
Q3 2021$164,000
+264.4%
6,183
+257.2%
0.01%
+200.0%
Q1 2021$45,000
-76.8%
1,731
-68.9%
0.00%
-77.8%
Q1 2019$194,000
+2.6%
5,562
-2.4%
0.02%
-5.3%
Q4 2018$189,000
+67.3%
5,700
+153.1%
0.02%
+137.5%
Q3 2018$113,000
+11.9%
2,252
+1.8%
0.01%
-11.1%
Q1 2018$101,000
-65.6%
2,212
-70.1%
0.01%
-66.7%
Q4 2017$294,000
+18.5%
7,393
+19.1%
0.03%
+12.5%
Q3 2017$248,000
+1358.8%
6,208
+607.9%
0.02%
+1100.0%
Q2 2016$17,000
-90.8%
877
-91.9%
0.00%
-93.9%
Q2 2015$184,000
+2528.6%
10,889
+1714.8%
0.03%
+1550.0%
Q1 2015$7,000
-85.7%
600
-89.2%
0.00%
-83.3%
Q1 2014$49,0005,5440.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders